Abbott acquisition positive, says Wells Fargo After Abbott announced its plan to acquire Chile-based branded generic pharmaceutical company CFR, Wells Fargo thinks that CFR is a good fit for Abbott's EPD growth platform from a strategic perspective. The firm reports that the deal expands EPD's footprint in Latin America and is expected to add 7c to the company's EPS in 2015. The firm keeps an Outperform rating on Abbott.
Abbott board increases quarterly dividend to 24c from 22c The board of Abbott increased the company's quarterly common dividend to 24c per share from 22c per share. The cash dividend is payable Feb. 13, 2015, to shareholders of record at the close of business on Jan. 15, 2015.